Tzortzis Vassilios, Mamoulakis Charalampos, Rioja Jorge, Gravas Stavros, Michel Martin C, de la Rosette Jean J M C H
Department of Urology, University of Thessaly School of Medicine, Larissa, Greece.
Drugs. 2009;69(6):677-92. doi: 10.2165/00003495-200969060-00003.
Although minimally invasive treatments for ureteral stones are efficacious, they are not free of complications and are associated with high cost. Medical expulsive therapy (MET) has recently emerged as an alternative strategy for the initial management of small distal ureteral stones. A MEDLINE search was undertaken to evaluate all currently available data on efficacy and safety of MET therapy in such patients. The specific mechanism of action on the ureteral smooth muscle and the emerging evidence of the efficacy (defined as either an increase in expulsion rate or a decrease in time to expulsion) and low-risk profile suggest that alpha-adrenergic receptor antagonists (alpha-blockers) and calcium channel antagonists should be the initial medical treatment in patients amenable to conservative therapy. NSAIDs and anticholinergics have not shown efficacy as single agents or in combination with alpha-blockers or nifedipine. Corticosteroids may provide a small additive effect when combined with either alpha-blockers or nifedipine.
尽管输尿管结石的微创治疗有效,但并非没有并发症,且成本高昂。药物排石疗法(MET)最近已成为小远端输尿管结石初始治疗的替代策略。我们进行了一项MEDLINE检索,以评估目前所有关于MET疗法在此类患者中的疗效和安全性的可用数据。对输尿管平滑肌的具体作用机制以及疗效的新证据(定义为排石率增加或排石时间缩短)和低风险特征表明,α-肾上腺素能受体拮抗剂(α-阻滞剂)和钙通道拮抗剂应作为适合保守治疗患者的初始药物治疗。非甾体抗炎药(NSAIDs)和抗胆碱能药物作为单一药物或与α-阻滞剂或硝苯地平联合使用均未显示出疗效。皮质类固醇与α-阻滞剂或硝苯地平联合使用时可能会产生较小的附加效果。